Esco Philippines Celebrates 14 Years of Innovation with Strategic New Office Relocation and Research Grant Awards

- The opening of a new, modern office enables greater agility, team collaboration, and closer connectivity with the Philippine market.
- A research grant judging session was also held during the inaugural event, reaffirming Esco’s commitment to supporting the scientific community in the Philippines.
PHILIPPINES, 23 June 2025 – Esco Lifesciences Group is proud to announce the opening of its new office in the Philippines, now located at Trium Square in Metro Manila. Strategically situated in the centre of the country’s business hub, the modern facility is designed to foster team collaboration and responsiveness to customers nationwide.
Marking 14 years of growth and commitment in the region, the new office enhances Esco Philippines’ ability to serve the local market with greater agility and connectivity.
To commemorate this milestone, the opening event featured Dr. Ursela Bigol, President of the Philippine Society for Microbiology (“PSM”), who joined the ribbon-cutting ceremony. This was followed by the judging session for the Esco–PSM Research Grant, a CSR initiative supporting early-career Filipino researchers in diverse microbiology fields. The programme provides up to PHP 100,000 in funding for selected projects in agricultural, aquatic, environmental, food, industrial, medical, and veterinary microbiology
“This new office shows Esco’s commitment to the Filipino scientific community and our growth in the country. As we mark 14 years, we continue to focus on innovation and impact through initiatives like the Esco-PSM Research Grant. We also thank the dedication of the Esco Philippines team, which helps drive our shared success,” said Ninoy Cahayon, Country Manager of Esco Philippines.
With strong presence in Southeast Asia, the Philippines has always been a strategic and important market for Esco Lifesciences Group. We are excited to start a new chapter with our office relocation and expanded research, strengthening Esco’s presence and investing in the future of science in the country.

